T5	Effect 0 36	Spontaneous nasal septal perforation
T7	Treatment 42 76	antiangiogenic bevacizumab therapy
T8	Drug 57 68	bevacizumab
T6	Adverse_event 37 41	with
E1	Adverse_event:T6